.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer last year for an enormous ...
.On the heels of a period 3 succeed that failed to thrill investors, Ironwood Pharmaceuticals is bac...
.Don't cease Monte Rosa Rehabs currently. The Boston-based biotech is enjoying after authorizing a t...
.Invite to this week's Chutes & Ladders, our summary of substantial management hirings, shootings...
.Celebrating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called ...
.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar seeking one ...
.GenSight Biologics is actually full weeks far from running out of cash. Once more. The biotech only...
.Monopar Therapies is actually recuperating a drug coming from the scrap heap of AstraZeneca's unusu...
.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts...
.After creating a genetics treatment relationship with Dyno Therapeutics in 2020, Roche is back for ...